Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
December 6, 2021
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
Yaiza Senent, Susana Inogés, Ascensión López-Díaz de Cerio, et al.
Oncotarget
|
February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancer
Daniel Ajona, Marcin Okrój, María J Pajares, et al.
Journal of Clinical Medicine
|
December 11, 2019
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
Maria Villalba, Francisco Exposito, Maria Jose Pajares, et al.
Molecular Cancer Research : MCR
|
February 26, 2014
TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC
Jackeline Agorreta, Jianting Hu, Dongxia Liu, et al.
Oncotarget
|
March 19, 2016
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Maria Villalba, Angel Diaz-Lagares, Miriam Redrado, et al.
International Journal of Cancer
|
January 30, 2014
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations
Anne-Marie Bleau, Javier Freire, María José Pajares, et al.
BMC Genomics
|
June 8, 2010
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
Ruben Pio, David Blanco, Maria Jose Pajares, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2016
Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies
Arantza Azpilikueta, Jackeline Agorreta, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2011
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
Mariano Ponz-Sarvisé, Paul A Nguewa, María J Pajares, et al.
Molecular Cancer
|
April 20, 2024
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Ander Puyalto, María Rodríguez-Remírez, Inés López, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
December 6, 2021
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
Yaiza Senent, Susana Inogés, Ascensión López-Díaz de Cerio, et al.
Oncotarget
|
February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancer
Daniel Ajona, Marcin Okrój, María J Pajares, et al.
Journal of Clinical Medicine
|
December 11, 2019
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
Maria Villalba, Francisco Exposito, Maria Jose Pajares, et al.
Molecular Cancer Research : MCR
|
February 26, 2014
TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC
Jackeline Agorreta, Jianting Hu, Dongxia Liu, et al.
Oncotarget
|
March 19, 2016
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Maria Villalba, Angel Diaz-Lagares, Miriam Redrado, et al.
International Journal of Cancer
|
January 30, 2014
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations
Anne-Marie Bleau, Javier Freire, María José Pajares, et al.
BMC Genomics
|
June 8, 2010
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
Ruben Pio, David Blanco, Maria Jose Pajares, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2016
Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies
Arantza Azpilikueta, Jackeline Agorreta, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2011
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
Mariano Ponz-Sarvisé, Paul A Nguewa, María J Pajares, et al.
Molecular Cancer
|
April 20, 2024
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Ander Puyalto, María Rodríguez-Remírez, Inés López, et al.
Page
of 10